Apollo Hospitals has reported a decline in its net profit for the third quarter of the fiscal year (Q3 FY25). The company posted a net profit of Rs 379.4 crore, marking a 4.12% drop compared to Rs 395.7 crore in the previous quarter (Q2 FY25).
In line with the profit decrease, Apollo Hospitals also saw a slight dip in its total income, which stood at Rs 5,590.7 crore in Q3, compared to Rs 5,627.5 crore in Q2 FY25.
Revenue And Operations Declines
Revenue from operations also experienced a decline of 1.79%, falling to Rs 5,527 crore in Q3 from Rs 5,627.5 crore in Q2. This drop was reflected in the company’s EBITDA, which decreased by 6.6% quarter-on-quarter (QoQ) to Rs 762 crore.
As a result, the EBITDA margin fell to 13.8%, a decrease of 81 basis points from the previous quarter.
The contraction in gross margins, which dropped by 135 basis points QoQ to 47.5%, contributed to this decline in profitability.
Despite the dip in financial performance, Apollo Hospitals declared an interim dividend of Rs 9 per share for the financial year ending March 31, 2025. This represents 180% of the face value of Rs 5 per share, reaffirming the company’s commitment to providing returns to its shareholders.
Apollo Focusses On Expansion Plans And Future Outlook
Looking ahead, Apollo Hospitals is focusing on expansion. The company plans to add 3,512 beds across 11 locations over the next three to four years, beginning in FY26. The hospital chain sees strong demand for healthcare services, particularly in tier-2 and tier-3 cities, where it aims to strengthen its presence.
Chairman Prathap C. Reddy emphasized the company’s dedication to ensuring quality healthcare access across India. He said, “From Mumbai to Varanasi and Chennai to Gurugram, we are committed to ensuring that quality healthcare is not a privilege but a fundamental right for all.”
He added that the results reflect Apollo’s ongoing growth story, which aligns with its mission to impact over a billion lives in India.
Apollo Hospitals’ Digital Health and Pharmacy
Apollo Hospitals’ digital health and pharmacy segments are also contributing to the company’s growth. These areas have seen a boost in demand, further driving its revenue despite challenges in the core hospital business.
On the stock market front, Apollo Hospitals’ shares closed 0.43% lower at Rs 6,761.25 on the NSE on Monday.
In a significant achievement, Apollo Hospitals completed over 1,000 robotic cardiac surgeries, underscoring its leadership in advanced cardiac care. This milestone further highlights the hospital chain’s continued innovation and commitment to providing cutting-edge healthcare solutions.
Also Read: Adani Group Partners With Mayo Clinic To Establish Rs 6,000 Crore Health Campuses In India
To read more such news, download Bharat Express news apps
